Hanmi Fine Chemical is an API manufacturer based in South Korea. It holds one active US drug master file and 5 valid CEPs across a filed portfolio of 7 molecules. Its filings concentrate with ARCSA (EC), MINSA (CR) and INVIMA (CO). Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 2 August 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Shihung-City, South Korea | Not on file |
| Siheung-si, South Korea | Not on file |
| HWASEONG, South Korea | Not on file |
| South, South Korea | 3009350213 |
| Molecule | Regulators | Docs |
|---|---|---|
| Cefixime | EDQM | 1 |
| Cefotaxime Sodium | EDQM | 1 |
| Ceftazidime | EDQM | 1 |
| Ceftazidime Pentahydrate With Sodium Carbonate For Injection | EDQM | 1 |
| Ceftriaxone | SFDA (Saudi Arabia) | 1 |
| Ceftriaxone Sodium | EDQM | 1 |
| Clopidogrel Napadisilate | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 5 | None |
| MINSA (CR) | 4 | None |
| INVIMA (CO) | 2 | None |
| NMPA (CN) | 2 | None |
| NPRA (MY) | 2 | None |
| US FDA | None | 1 |
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Hanmi Fine Chemical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.